FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnost

February 4, 2020 FDA

Today, FDA issued an EUA to enable emergency use of CDC’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. To date, this test has been limited to use at CDC laboratories; today’s authorization allows use of the test at any CDC-qualified lab across the country.

Previous Article
FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals
FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals

FDA analysis published today advances the understanding of intentional genomic alterations in animals.

Next Article
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to

The U.S. Food and Drug Administration and the Federal Trade Commission signed a joint statement regarding e...